BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1306098)

  • 21. Bladder cancer epidemiology and pathogenesis.
    Ross RK; Jones PA; Yu MC
    Semin Oncol; 1996 Oct; 23(5):536-45. PubMed ID: 8893866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A molecular genetic model of human bladder carcinogenesis.
    Reznikoff CA; Kao C; Messing EM; Newton M; Swaminathan S
    Semin Cancer Biol; 1993 Jun; 4(3):143-52. PubMed ID: 8318690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiology of bladder cancer.
    Shirai T
    Semin Urol; 1993 Aug; 11(3):113-26. PubMed ID: 8210833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
    Talaska G; Schamer M; Skipper P; Tannenbaum S; Caporaso N; Unruh L; Kadlubar FF; Bartsch H; Malaveille C; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):61-6. PubMed ID: 1845172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemoglobin-carcinogen adducts as molecular biomarkers in epidemiology.
    Tannenbaum SR
    Princess Takamatsu Symp; 1990; 21():351-60. PubMed ID: 2134688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study.
    Karagas MR; Park S; Warren A; Hamilton J; Nelson HH; Mott LA; Kelsey KT
    Cancer Lett; 2005 Feb; 219(1):63-9. PubMed ID: 15694665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cigarette smoking and chromosome 9 alterations in bladder cancer.
    Zhang ZF; Shu XM; Cordon-Cardo C; Orlow I; Lu ML; Millon TV; Cao PQ; Connolly-Jenks C; Dalbagni G; Lianes P; Lacombe L; Reuter VE; Scher H
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):321-6. PubMed ID: 9149891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher DNA adduct levels in urinary bladder and prostate of slow acetylator inbred rats administered 3,2'-dimethyl-4-aminobiphenyl.
    Jiang W; Feng Y; Hein DW
    Toxicol Appl Pharmacol; 1999 May; 156(3):187-94. PubMed ID: 10222311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer.
    Lin J; Kadlubar FF; Spitz MR; Zhao H; Wu X
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1832-6. PubMed ID: 16030125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA adduct burden and tobacco carcinogenesis.
    Wiencke JK
    Oncogene; 2002 Oct; 21(48):7376-91. PubMed ID: 12379880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke.
    Alberg AJ; Kouzis A; Genkinger JM; Gallicchio L; Burke AE; Hoffman SC; Diener-West M; Helzlsouer KJ; Comstock GW
    Am J Epidemiol; 2007 Mar; 165(6):660-6. PubMed ID: 17204516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolic polymorphisms and the cancer risk: the evaluation of epidemiological studies].
    Vineis P; Landi MT; Caporaso N
    Med Lav; 1992; 83(6):557-75. PubMed ID: 1296137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of disease: The epidemiology of bladder cancer.
    Pelucchi C; Bosetti C; Negri E; Malvezzi M; La Vecchia C
    Nat Clin Pract Urol; 2006 Jun; 3(6):327-40. PubMed ID: 16763645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular dosimetry of aromatic amines in human populations.
    Skipper PL; Tannenbaum SR
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):17-21. PubMed ID: 7889842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of biomarkers in epidemiology: the example of bladder cancer.
    Vineis P
    Toxicol Lett; 1992 Dec; 64-65 Spec No():463-7. PubMed ID: 1471198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tobacco and cancer: epidemiology and the laboratory.
    Vineis P; Caporaso N
    Environ Health Perspect; 1995 Feb; 103(2):156-60. PubMed ID: 7737063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California.
    Yu MC; Skipper PL; Taghizadeh K; Tannenbaum SR; Chan KK; Henderson BE; Ross RK
    J Natl Cancer Inst; 1994 May; 86(9):712-6. PubMed ID: 8158701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interindividual variation in carcinogen metabolism and bladder cancer risk.
    Vineis P; Ronco G
    Environ Health Perspect; 1992 Nov; 98():95-9. PubMed ID: 1486869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers.
    Bartsch H; Caporaso N; Coda M; Kadlubar F; Malaveille C; Skipper P; Talaska G; Tannenbaum SR; Vineis P
    J Natl Cancer Inst; 1990 Dec; 82(23):1826-31. PubMed ID: 2250298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.